Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Gain Therapeutics, Inc. | Principal Accounting and Financial Officer | Employee Stock Option (right to buy) | 50K | Mar 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GANX | Gain Therapeutics, Inc. | Mar 21, 2024 | 1 | $0 | 4 | Mar 25, 2024 | Principal Accounting and Financial Officer |
GANX | Gain Therapeutics, Inc. | Mar 23, 2023 | 1 | $0 | 4 | Mar 27, 2023 | Principal Accounting Officer |
GANX | Gain Therapeutics, Inc. | Dec 12, 2022 | 0 | $0 | 3 | Dec 21, 2022 | Principal Accounting Officer |